# A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)

> **NCT00509275** · PHASE1 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 120 (actual)

## Conditions studied

- Tinea Pedis

## Interventions

- **DRUG:** W0027
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00509275
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00509275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00509275, "A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00509275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*